Abstract
Objective: The objective of this study was to determine the frequency of seizures in both MOG-Ab positive and negative acute disseminated encephalomyelitis (ADEM) and evaluate if seizures at presentation are predictive of a relapsing disease course and post ADEM epilepsy.
Background: Although initially thought to be a predominantly white matter disease, there is a growing report of both adult and children with myelin oligodendrocyte glycoprotein antibody (MOG-Ab) associated disease presenting with grey matter disease and seizures.
Design/Methods: Children presenting with ADEM were identified from three tertiary paediatric neurology centres between 2005 and 2017 and case notes reviewed. MOG-Ab were tested as part of the clinical evaluation of children with demyelination.
Results: 72 children were identified. MOG-Ab was positive in 48 (67%) of cases. 28 (39%) of those children went on to have a further neurological relapse. Relapses were more common in MOG-Ab positive children (26/48 vs 2/24; p=0.001).
15/72(20.8%) children had seizures during the acute presentation with ADEM. There was a trend towards more seizures at onset in the MOG-Ab positive group (13/48 vs 2/24; p=0.07). A diagnosis of post ADEM epilepsy was reported in 14/73(19.4%) and there was also a trend towards more ongoing seizures at last follow-up in the MOG-Ab positive group (12/48 vs 2/24; p=0.12).
Seizure at onset were more frequent in the relapsing group than those with monophasic disease (10/28 vs 5/44; p=0.01); and ongoing seizures were more common in the relapsing group (9/28 vs 4/40; p=0.01). The odds ratio of relapsing disease with seizures at onset of first episode of demyelination was 4.3 (95% CI 1.3–14.5; p=0.02).
Conclusions: MOG-Ab positivity was associated with a higher rate of relapse flowing ADEM. Seizures at first presentation is predictive of a relapsing disease course. These findings have both diagnostic and treatment implications.
Disclosure: Dr. Rossor has nothing to disclose. Dr. Wright has nothing to disclose. Dr. Duignan has nothing to disclose. Dr. Ciccarelli has nothing to disclose. Dr. Das has nothing to disclose. Dr. Wassmer has nothing to disclose. Dr. Lim has nothing to disclose. Dr. Hemingway has nothing to disclose. Dr. Hacohen has nothing to disclose.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken